KEYNOTE-905
Interviews and expert commentary tagged “KEYNOTE-905” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
ESMO 2025; Christof Vulsteke MD PhD: Perioperative Enfortumab Vedotin Therapy With Pembrolizumab Boosts Event-Free and Overall Survival in Platinum-Ineligible Patients with Muscle-Invasive Bladder Cancer: KEYNOTE-905 study
A big step forwards in the management of muscle invasive bladder cancer in which platinum cannot be used has been taken in the KEYNOTE-905 study of perioperative antibody drug conjugate thereapy with
30 October 2025
0:00